Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company is engaged in a pharmaceutical company, develops, manufactures, and markets pharmaceutical products.
Ajanta Pharma Limited, is a listed public company incorporated on 31 December, 1979. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital is INR 30.00 cr and the total paid-up capital is INR 25.18 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
16.41%
60.08%
44.48%
5.15%
-2.03%
2.29
7.69
3.98
6.44
10.82
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(63)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CitiBank N.A.
No. of Loans: 1
Total Amount : 35.0 cr
IDBI Bank Limited
No. of Loans: 1
Total Amount : 10.0 cr
SBM BANK (INDIA) LIMITED
No. of Loans: 1
Total Amount : 10.0 cr
RBL Bank Limited
No. of Loans: 1
Total Amount : 10.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Yogesh Mannalal Agrawal
Shareholder
|
00073673 | 17 years |
| Director | Mannalal Bhagwandas Agrawal | 00073828 | 45 years |
| Whole-time Director | Madhusudan Bhagwandas Agrawal | 00073872 | 45 years |
| Whole-time Director | Rajesh Mannalal Agrawal
Shareholder
|
00302467 | 12 years |
| Director | Medha Vinay Joshi | 00328174 | 1 years |
| CFO | Arvind Kanhaiyalal Agrawal
Shareholder
|
<HIDDEN> | 9 years |
| CS | Gaurang Chinubhai Shah
Shareholder
|
<HIDDEN> | 11 years |
| Director | David Paul Rasquinha | 01172654 | 1 years |
| Director | Rajesh Shashikant Dalal | 03504969 | 1 years |
| Director | Simi Manohar Lal Thapar | 10470498 | 1 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| GABS INVESTMENTS PRIVATE LIMITED |
Active
|
1.8 L | 2 | Maharashtra |
| NUVENTA ENTERPRISES LLP |
Under process of striking off
|
1.0 L | 1 | Maharashtra |
| SIRIEN MIDC INFRASTRUCTURE LIMITED |
Strike Off
|
5.0 L | 2 | Maharashtra |
| AGARWAL GLOBAL FOUNDATION |
Active
|
0.0 | 1 | Maharashtra |
| SAMTA MINES AND MINERALS LIMITED |
Active
|
98.0 Cr | 1 | Maharashtra |
| VYATA SPACE CONCEPTS PRIVATE LIMITED |
Active
|
5.0 L | 1 | Maharashtra |
| INSPIRA PROJECTS LIMITED |
Active
|
70.9 L | 1 | Maharashtra |
| KWERA LANDS PRIVATE LIMITED |
Active
|
5.0 L | 1 | Maharashtra |
| INSPIRA SUN SYSTEMS PRIVATE LIMITED |
Strike Off
|
5.0 L | 1 | Maharashtra |
| INSPIRA INFRA (AURANGABAD) LIMITED |
Active
|
14.0 Cr | 1 | Maharashtra |
| GENCREST PRIVATE LIMITED |
Active
|
25.0 Cr | 1 | Maharashtra |
| INSPIRA REALTY & INFRA PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Maharashtra |
| INSPIRA BUILDCON PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| INSPIRA EXIM ENTERPRISE PRIVATE LIMITED |
Active
|
11.0 Cr | 1 | Maharashtra |
| INSPIRA DEVELOPERS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| Inspira Estate LLP |
Active
|
1.0 L | 1 | sh |
| Inspira Bay LLP |
Active
|
1.0 L | 1 | sh |
| INSPIRA REALTY LLP |
Active
|
5.3 Cr | 1 | Maharashtra |
| GENCREST LLP |
Converted to CMP and Dissolved
|
10.0 Cr | 1 | Maharashtra |
| LENEXIS FOODWORKS PRIVATE LIMITED |
Active
|
24.0 Cr | 1 | Maharashtra |
| SBFC FINANCE LIMITED |
Active
|
1,076.6 Cr | 1 | Maharashtra |
| RITEAID ENTERPRISES LLP |
Active
|
1.0 L | 1 | Maharashtra |
| AQUANOMICS SYSTEMS LIMITED |
Active
|
95.0 L | 1 | Maharashtra |
| BHARAT HANDLOOM MARKETING COMPANY LIMITED |
Strike Off
|
2.0 Cr | 1 | Delhi |
| UNITY SMALL FINANCE BANK LIMITED |
Active
|
2,953.4 Cr | 1 | Delhi |
| ION EXCHANGE (INDIA) LIMITED |
Active
|
14.7 Cr | 1 | Maharashtra |
| BIOGENOMICS LIMITED |
Active
|
383.5 Cr | 1 | Pondicherry |
| LAXMI DENTAL PRIVATE LIMITED |
Active
|
17.2 Cr | 1 | Maharashtra |
| ENTERO HEALTHCARE SOLUTIONS LIMITED |
Active
|
35.5 Cr | 1 | Haryana |
| ASCENT MEDITECH LIMITED |
Active
|
1.2 Cr | 1 | Gujarat |
| CSI RENTING INDIA PRIVATE LIMITED |
Active
|
27.5 Cr | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Ajanta Pharma (Mauritius) Limited | Mauritius | - | - |
| Ajanta Pharma Philippines Inc. | Philippines | - | - |
| Ajanta Pharma USA Inc. | United States | - | - |
| Ajanta Pharma Nigeria Ltd. | Nigeria | - | - |
The incorporation date of AJANTA PHARMA LIMITED is 31 December, 1979
The authorized share capital of AJANTA PHARMA LIMITED is INR ₹ 30.0 Cr.
The paid-up capital of AJANTA PHARMA LIMITED is INR ₹ 25.2 Cr.
The registered address of AJANTA PHARMA LIMITED is AJANTA HOUSE 98 GOVTINDUSTRIAL AREA CHARKOP KANDIVLI(WEST) NA MUMBAI Maharashtra - 400067
The CIN number of AJANTA PHARMA LIMITED is L24230MH1979PLC022059.
Expand
Delete
Collapse
See
details
